AB
CTIC

Amalgamated Bank’s CTI BioPharma Corp. (DE) Common Stock CTIC Stock Holding History

Amalgamated Bank’s Portfolio CTIC Stock Details CTIC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-10,726
Closed -$45K – 3226
2023
Q1 		$45K Sell
10,726
-2,380
-18% -$12.4K ﹤0.01% 2348
2022
Q4 		$79K Hold
13,106
– – ﹤0.01% 2231
2022
Q3 		$76K Buy
13,106
+807
+7% +$5.03K ﹤0.01% 2278
2022
Q2 		$73K Buy
+12,299
New +$63K ﹤0.01% 2311
2016
Q2 		– Sell
-2,262
Closed -$12K – 1439
2016
Q1 		$12K Buy
2,262
+274
+14% +$2.19K ﹤0.01% 1289
2015
Q4 		$24K Buy
1,988
+270
+16% +$3.6K ﹤0.01% 1187
2015
Q3 		$25K Buy
1,718
+16
+0.9% +$276 ﹤0.01% 1284
2015
Q2 		$33K Buy
1,702
+198
+13% +$3.82K ﹤0.01% 1347
2015
Q1 		$27K Buy
1,504
+60
+4% +$1.35K ﹤0.01% 925
2014
Q4 		$34K Buy
1,444
+135
+10% +$3.12K 0.01% 846
2014
Q3 		$32K Hold
1,309
– – ﹤0.01% 833
2014
Q2 		$37K Sell
1,309
-33
-2% -$992 0.01% 862
2014
Q1 		$46K Sell
1,342
-7
-0.5% -$239 0.01% 821
2013
Q4 		$26K Buy
+1,349
New +$24.6K ﹤0.01% 833

Other funds holding CTIC

UBS AM
UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return

Amalgamated Bank's CTIC Position: Q2 2023 in Review

Amalgamated Bank sold out of CTI BioPharma Corp. (DE) Common Stock (CTIC) in Q2 2023, closing a stake of 10,726 shares — an estimated $45K sold.

Amalgamated Bank first reported a position in CTIC in Q4 2013 and held it in 14 quarters. The position peaked at $79K in Q4 2022. 2 funds tracked by Wall St. Rank hold CTIC as of Q2 2023.

  • Amalgamated Bank reported no remaining CTI BioPharma Corp. (DE) Common Stock position as of Q2 2023 after selling out during the quarter.
  • Amalgamated Bank sold 10,726 CTI BioPharma Corp. (DE) Common Stock shares in Q2 2023, an estimated $45K.
  • Amalgamated Bank first reported a position in CTI BioPharma Corp. (DE) Common Stock in Q4 2013 and held it in 14 quarters.
  • Amalgamated Bank's CTI BioPharma Corp. (DE) Common Stock position peaked at $79K in Q4 2022.
  • 2 funds tracked by Wall St. Rank held CTI BioPharma Corp. (DE) Common Stock as of Q2 2023.

Based on Amalgamated Bank's 13F filing for Q2 2023, filed 11 Aug 2023.